Infosys

At a meeting of the Pistoia Alliance last week, six vendors unveiled four cloud-based proof-of-concept platforms designed to provide a service for pharma to store and mine proprietary and public gene databases.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.